116 related articles for article (PubMed ID: 14529415)
1. SRC family kinases: potential targets for the treatment of human cancer and leukemia.
Warmuth M; Damoiseaux R; Liu Y; Fabbro D; Gray N
Curr Pharm Des; 2003; 9(25):2043-59. PubMed ID: 14529415
[TBL] [Abstract][Full Text] [Related]
2. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
4. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
5. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
Kline CL; Irby RB
Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
[TBL] [Abstract][Full Text] [Related]
6. The SRC-induced mesenchymal state in late-stage colon cancer cells.
Avizienyte E; Brunton VG; Fincham VJ; Frame MC
Cells Tissues Organs; 2005; 179(1-2):73-80. PubMed ID: 15942195
[TBL] [Abstract][Full Text] [Related]
7. SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
Johnson FM; Gallick GE
Anticancer Agents Med Chem; 2007 Nov; 7(6):651-9. PubMed ID: 18045060
[TBL] [Abstract][Full Text] [Related]
8. Combining Src inhibitors and aromatase inhibitors: a novel strategy for overcoming endocrine resistance and bone loss.
Hiscox S; Barrett-Lee P; Borley AC; Nicholson RI
Eur J Cancer; 2010 Aug; 46(12):2187-95. PubMed ID: 20471823
[TBL] [Abstract][Full Text] [Related]
9. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
Tan M; Li P; Klos KS; Lu J; Lan KH; Nagata Y; Fang D; Jing T; Yu D
Cancer Res; 2005 Mar; 65(5):1858-67. PubMed ID: 15753384
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.
Crossthwaite AJ; Valli H; Williams RJ
J Neurochem; 2004 Mar; 88(5):1127-39. PubMed ID: 15009668
[TBL] [Abstract][Full Text] [Related]
11. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
Hu Y; Liu Y; Pelletier S; Buchdunger E; Warmuth M; Fabbro D; Hallek M; Van Etten RA; Li S
Nat Genet; 2004 May; 36(5):453-61. PubMed ID: 15098032
[TBL] [Abstract][Full Text] [Related]
12. The role of Src in colon cancer and its therapeutic implications.
Chen J; Elfiky A; Han M; Chen C; Saif MW
Clin Colorectal Cancer; 2014 Mar; 13(1):5-13. PubMed ID: 24361441
[TBL] [Abstract][Full Text] [Related]
13. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: in vitro and in vivo studies.
He H; Hirokawa Y; Levitzki A; Maruta H
Cancer J; 2000; 6(4):243-8. PubMed ID: 11038144
[TBL] [Abstract][Full Text] [Related]
14. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.
Kansra S; Stoll SW; Johnson JL; Elder JT
Mol Pharmacol; 2005 Apr; 67(4):1145-57. PubMed ID: 15615697
[TBL] [Abstract][Full Text] [Related]
15. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
[TBL] [Abstract][Full Text] [Related]
16. Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.
Stewart TA; Azimi I; Brooks AJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
Int J Biochem Cell Biol; 2016 Jul; 76():64-74. PubMed ID: 27163529
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.
Mason LH; Willette-Brown J; Taylor LS; McVicar DW
J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
[TBL] [Abstract][Full Text] [Related]
19. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells.
Azijli K; Yuvaraj S; Peppelenbosch MP; Würdinger T; Dekker H; Joore J; van Dijk E; Quax WJ; Peters GJ; de Jong S; Kruyt FA
J Cell Sci; 2012 Oct; 125(Pt 19):4651-61. PubMed ID: 22797920
[TBL] [Abstract][Full Text] [Related]
20. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
